1Roxas M. Herpes Zoster and Postherpetic Neuralgia: Diagnosis and Therapeutic Considerations. Altern Med Rev, 2006, 11 (2): 102-113.
2Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis, 2007, 44 (Suppl 1): S1-S26.
3Shen MC, Lin HH, Lee SS, et al. Double-blind, randomized, acyclovir-controlled, parallel-group train comparing the safety and efficacy of famciclovir and acyclovir in patients with tincomplicated herpes zoster. J Microbiol Immunol Infect, 2004, 37(2): 75-81.
4Decroix J, Partsch H, Gonzalez R, et al. Factors influencing pain outcome in herpes zoster : an observational study with valacyclovir.Valaciclovir International Zoster Assessment Group (VIZA). J Eur Acad Dermatol Venereol, 2000, 14( 1 ): 23-33.
5Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? J Fam Pract, 2000, 49 (3): 255-264.
6Wood MJ, Kay R, Dworkin RH, et al. Oral aeyclovir therapy accelerates pain resolution in patients with herpes zoster : a meta-analysis of placebo-controlled trials. Clin Infect Dis, 1996, 22(2): 341-347.
7Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother, 1995, 39(7): 1546-1553.
8Tyring SK, Beutner KR, Tucker BA, et al. Anfiviral therapy for herpes zoster : randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med, 2000, 9(9): 863-869.
9Wassilew S, Collaborative Brivudin PHN Study Group. Brivudin compared with famcielovir in the treatment of herpes zoster : effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. J Eur Acad Dermatol Venereol, 2005, 19( 1 ): 47-55.
10Tyring S, Engst R, Corriveau C, et al. Famciclovir for ophthalmic zoster : a randomized acyclovir controlled study. Br J Ophthalmol, 2001, 85(5): 576-581.
